Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for SRBCF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
July 31, 2024 -2.508M
April 30, 2024 -2.228M
January 31, 2024 -2.090M
October 31, 2023 -1.809M
July 31, 2023 -1.006M
April 30, 2023 -0.6104M
January 31, 2023 -0.265M
October 31, 2022 0.1573M
July 31, 2022 0.737M
April 30, 2022 0.7193M
January 31, 2022 -0.3756M
October 31, 2021 -0.0754M
July 31, 2021 -0.569M
April 30, 2021 -0.2519M
January 31, 2021 -0.2977M
October 31, 2020 0.0355M
July 31, 2020 0.5029M
April 30, 2020 1.362M
January 31, 2020 1.873M
October 31, 2019 1.666M
July 31, 2019 1.862M
April 30, 2019 -0.9974M
January 31, 2019 -2.155M
October 31, 2018 -1.722M
July 31, 2018 -1.821M
Date Value
April 30, 2018 -1.969M
January 31, 2018 -1.696M
October 31, 2017 -1.607M
July 31, 2017 -0.113M
April 30, 2017 0.2602M
January 31, 2017 0.7636M
October 31, 2016 1.166M
July 31, 2016 1.585M
April 30, 2016 1.993M
January 31, 2016 1.680M
October 31, 2015 1.795M
July 31, 2015 1.366M
April 30, 2015 1.286M
January 31, 2015 0.8466M
October 31, 2014 1.588M
July 31, 2014 1.504M
April 30, 2014 2.216M
January 31, 2014 1.953M
October 31, 2013 2.147M
July 31, 2013 1.703M
April 30, 2013 1.853M
January 31, 2013 1.394M
October 31, 2012 1.701M
July 31, 2012 2.404M
April 30, 2012 2.814M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Xenon Pharmaceuticals, Inc. 1.242B
Psyence Biomedical Ltd. 11.87M
Aurinia Pharmaceuticals, Inc. 614.86M
enGene Therapeutics, Inc. 255.17M
Medicus Pharma Ltd. -1.243M